Charles Rhyee
Stock Analyst at TD Cowen
(2.11)
# 3,007
Out of 5,240 analysts
84
Total ratings
43.86%
Success rate
-4.97%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $105 → $110 | $98.11 | +12.12% | 2 | May 11, 2026 | |
| GDRX GoodRx Holdings | Maintains: Buy | $3 → $4 | $2.61 | +53.26% | 9 | May 11, 2026 | |
| AMWL American Well | Maintains: Hold | $5 → $8 | $7.73 | +3.49% | 4 | May 6, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $60 → $65 | $56.50 | +15.04% | 1 | May 4, 2026 | |
| OPCH Option Care Health | Maintains: Hold | $37 → $23 | $19.78 | +16.28% | 3 | May 1, 2026 | |
| CAH Cardinal Health | Maintains: Buy | $251 → $255 | $186.35 | +36.84% | 4 | May 1, 2026 | |
| FTRE Fortrea Holdings | Upgrades: Buy | $15 | $14.47 | +3.66% | 5 | Mar 9, 2026 | |
| IQV IQVIA Holdings | Upgrades: Buy | $174 → $213 | $172.38 | +23.56% | 4 | Mar 9, 2026 | |
| VEEV Veeva Systems | Maintains: Buy | $380 → $300 | $155.73 | +92.64% | 5 | Mar 5, 2026 | |
| TDOC Teladoc Health | Maintains: Hold | $8 → $6 | $6.79 | -11.63% | 7 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $251 → $235 | $162.85 | +44.30% | 7 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $5.18 | +73.75% | 3 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $183 → $120 | $117.38 | +2.23% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $462 → $419 | $423.76 | -1.12% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $333 → $338 | $300.71 | +12.40% | 2 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,000 → $1,012 | $737.18 | +37.28% | 5 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $46 | $38.71 | +18.83% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $400 | $255.68 | +56.45% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $5.62 | +896.44% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $360 → $280 | $8.10 | +3,356.79% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $4.13 | +1,110.65% | 2 | Jun 21, 2022 |
CVS Health
May 11, 2026
Maintains: Buy
Price Target: $105 → $110
Current: $98.11
Upside: +12.12%
GoodRx Holdings
May 11, 2026
Maintains: Buy
Price Target: $3 → $4
Current: $2.61
Upside: +53.26%
American Well
May 6, 2026
Maintains: Hold
Price Target: $5 → $8
Current: $7.73
Upside: +3.49%
BrightSpring Health Services
May 4, 2026
Maintains: Buy
Price Target: $60 → $65
Current: $56.50
Upside: +15.04%
Option Care Health
May 1, 2026
Maintains: Hold
Price Target: $37 → $23
Current: $19.78
Upside: +16.28%
Cardinal Health
May 1, 2026
Maintains: Buy
Price Target: $251 → $255
Current: $186.35
Upside: +36.84%
Fortrea Holdings
Mar 9, 2026
Upgrades: Buy
Price Target: $15
Current: $14.47
Upside: +3.66%
IQVIA Holdings
Mar 9, 2026
Upgrades: Buy
Price Target: $174 → $213
Current: $172.38
Upside: +23.56%
Veeva Systems
Mar 5, 2026
Maintains: Buy
Price Target: $380 → $300
Current: $155.73
Upside: +92.64%
Teladoc Health
Feb 26, 2026
Maintains: Hold
Price Target: $8 → $6
Current: $6.79
Upside: -11.63%
Feb 20, 2026
Maintains: Buy
Price Target: $251 → $235
Current: $162.85
Upside: +44.30%
Feb 20, 2026
Maintains: Buy
Price Target: $6 → $9
Current: $5.18
Upside: +73.75%
Feb 18, 2026
Upgrades: Buy
Price Target: $183 → $120
Current: $117.38
Upside: +2.23%
Feb 18, 2026
Upgrades: Hold
Price Target: $462 → $419
Current: $423.76
Upside: -1.12%
Feb 9, 2026
Maintains: Buy
Price Target: $333 → $338
Current: $300.71
Upside: +12.40%
Feb 5, 2026
Maintains: Buy
Price Target: $1,000 → $1,012
Current: $737.18
Upside: +37.28%
Jan 12, 2026
Initiates: Buy
Price Target: $46
Current: $38.71
Upside: +18.83%
Nov 10, 2025
Maintains: Buy
Price Target: $350 → $400
Current: $255.68
Upside: +56.45%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $5.62
Upside: +896.44%
Aug 16, 2022
Maintains: Outperform
Price Target: $360 → $280
Current: $8.10
Upside: +3,356.79%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $4.13
Upside: +1,110.65%